Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion type Assertion NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_head.
- NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion description "[Analyses obtained with 164 lymph nodes from patients free of cancer and 15 nodes harboring metastases established a threshold for metastatic disease of approximately 200 GCC mRNA copies/mug total RNA, with a sensitivity of 93% and specificity of 97%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_provenance.
- NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion evidence source_evidence_literature NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_provenance.
- NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion SIO_000772 16899600 NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_provenance.
- NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion wasDerivedFrom befree-20140225 NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_provenance.
- NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_assertion wasGeneratedBy ECO_0000203 NP781307.RAYeLP9tp64uOEtPaKYr7LnUBReKEUnCQAAKpTPcV4Ke0130_provenance.